XML 17 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:    
Net loss $ (130,947) $ (1,429)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,507 2,677
Stock-based compensation expense 2,610 2,176
Inventory impairments and abandonments 450 0
Deferred and other income tax expense (benefit) 107,795 (2,707)
Write-off of deposit on legacy land investment 0 2,700
Gain on sale of fixed assets (65) (46)
Change in allowance for doubtful accounts (1) (4)
Income Loss from Unconsolidated Entities (88) 22
Cash distributions of income from unconsolidated entities 50 6
Non-cash loss on extinguishment of debt 3,173 0
Changes in operating assets and liabilities:    
Decrease in accounts receivable 4,520 1,433
Decrease in income tax receivable 0 4
Increase in inventory (83,205) (39,543)
Decrease in other assets 1,252 1,906
Decrease in trade accounts payable (5,949) (17,444)
Decrease in other liabilities (4,502) (12,541)
Net cash used in operating activities (102,224) (62,834)
Cash flows from investing activities:    
Capital expenditures (3,702) (2,874)
Proceeds from sale of fixed assets 84 46
Investments in unconsolidated entities (421) (1,397)
Return of capital from unconsolidated entities 0 1,621
Net cash used in investing activities (4,039) (2,604)
Cash flows from financing activities:    
Repayment of debt (401,481) (2,525)
Proceeds from issuance of new debt 400,000 0
Debt issuance costs (5,649) (340)
Other financing activities (1,322) (387)
Net cash used in financing activities (8,452) (3,252)
Decrease in cash, cash equivalents and restricted cash (114,715) (68,690)
Cash, cash equivalents and restricted cash at beginning of period 304,609 243,276
Cash, cash equivalents and restricted cash at end of period $ 189,894 $ 174,586